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Abstract
Background: Memory CD8 T cells form an essential part of protective immunity against viral infections. Antigenic load,
costimulation, CD4-help, cytokines and chemokines fluctuate during the course of an antiviral immune response thus
affecting CD8 T cell activation and memory conversion.
Methodology/Principal Findings: In the present study, naı ¨ve TCR transgenic LCMV-specific P14 CD8 T cells engaged at a
late stage during the acute antiviral LCMV response showed reduced expansion kinetics but greater memory conversion in
the spleen. Such late activated cells displayed a memory precursor effector phenotype already at the peak of the systemic
antiviral response, suggesting that the environment determined their fate during antigen encounter. In the spleen, the
majority of late transferred cells exhibited a central memory phenotype compared to the effector memory displayed by the
early transferred cells. Increasing the inflammatory response by exogenous administration of IFNc, PolyI:C or CpG did not
affect memory conversion in the late transferred group, suggesting that the diverging antigen load early versus later during
acute infection had determined their fate. In agreement, reduction in the LCMV antigenic load after ribavirin treatment
enhanced the contribution of early transferred cells to the long lasting memory pool.
Conclusions/Significance: Our results show that naı ¨ve CD8 cells, exposed to reduced duration or concentration of antigen
during viral infection convert into memory more efficiently, an observation that could have significant implications for
vaccine design.
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Introduction
The generation of memory T cells is a crucial process for
developing novel ways to prevent viral infections and certain forms
of cancer [1–3]. Following exposure to antigen, T cells proceed
through three defined phases: activation and clonal expansion,
contraction and memory conversion [4–6]. Memory T cell
development can be influenced by the antigen dose, the strength
of the T cell receptor (TCR)-antigen interaction, costimulation,
type of antigen presenting cells (APCs), the participation of CD4
helper/regulatory T cells and the cytokines and/or chemokine
environment [7–13]. Two major memory T cell populations have
been described based on their location and effector functions.
Central memory (CM) T cells (CD44
hiCD62L
hiCCR7
+) are
located in secondary lymphoid tissues and possess little cytotoxic
activity, while effector memory (EM) T cells (CD62L
loCCR7
2),
which reside in non-lymphoid tissues are cytotoxic and rapidly
acquire effector function [14–18].
T cell activation and differentiation during the course of an
infectioncanbe influenced bychanges inpathogenload [19].Asthe
amount of antigen decreases during the course of an acute infection,
naı ¨veT cellsthatareintroducedatlatestagesseemtoproliferateless
and acquire different properties, such as decreased CD62L down-
regulation [20,21]. However, what determines EM versus CM and
how the timing of viral infection affects this differentiation process
are still open questions in the field. It is not known whether naı ¨ve T
cells activated at the peak viral load during antigen abundance,
versus peak viral clearance when the antigen load is low, have
different capacities for T cell memory formation.
In addition to antigen levels, cytokines are known to play crucial
roles in memory T cell survival and differentiation [22]. IL-7, one
of the most well studied cytokines in mediating survival of naı ¨ve T
cells seems to contribute to survival, and to a lesser extent, to basal
homeostatic proliferation of memory T cells [23–25]. Upon
TCR activation, IL-7Ra (CD127) is initially down-regulated on
populations of activated effectors cells and increased CD127 levels
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memory T cells [26]. More recent evidence suggests that
coordinate expression of CD127 and killer cell lectin-like receptor
G1 (KLRG-1), distinguishes short-lived effector cells (SLEC) from
those destined to develop into long-lived memory T cells. SLEC
display a KLRG-1
hiCD127
lo phenotype, whereas memory
precursor effector cells (MPECs) exhibit a KLRG-1
loCD127
hi
phenotype [27]. The decision between SLEC and MPEC fates can
be regulated by the inflammatory environment, which subse-
quently induces specific transcriptional programs in primed CD8
T cells [28–30]. In addition, the ability of effector CD8 T cells to
produce IL-2 has been partially associated with stable memory
development [31,32]. Whether the inflammatory environment
and/or antigen load are more predominant regulator of memory
T cell development has not been resolved.
In the present study, we demonstrate that the timing at which
naı ¨ve MHC class-I restricted, LCMV-specific, TCR transgenic
(Tg) P14 T cell enter the primary immune response to LCMV can
affect their expansion and capacity to differentiate into memory T
cells. Naı ¨ve CD8 T cells activated in conditions of reduced antigen
load during LCMV infection either through late introduction in
infection or after ribavirin anti-viral treatment, converted into
memory more efficiently than naı ¨ve CD8 T cells activated early
during infection. As The majority of late transferred cells present
at the peak of the response exhibited a KLRG1
lo phenotype,
characteristic of memory precursor CD8 T cells [33]. In addition,
late tranferred cells did not ‘‘contract’’ and remained as memory
cells. They displayed a gradual shift from a CD44
hiCD62L
lo (EM)
phenotype to a CD44
hiCD62L
hi (CM) phenotype and increased
levels of IL-2 production, in agreement with previously published
results [31,32]. By contrast, naı ¨ve CD8 T cells transferred cells
early in the course of LCMV infection, prior to peak viral load,
were predominately EM, CD44
hiCD62L
lo. Increasing the inflam-
matory milieu after treatment with CpG, poly I:C or IFNc had no
significant effect on the late transferred cells, indicating that
antigen load during infection was likely the main factor that
determined their survival and memory conversion. In agreement,
ribavirin treatment significantly reduced LCMV viral load and
consequently the expansion and contraction phases of early
transferred naive P14 TCR Tg cells. The conversion rate of early
transferred naı ¨ve CD8 T cells into memory was significantly
augmented, in ribavirin-treated versus untreated mice and was
similar to that of late transferred cells. Our results suggest an
inverse correlation between the degree of antigen-specific
expansion and memory conversion for CD8 T cells, which may
aid in the development of more effective vaccines and perhaps the
treatment of autoimmune, CD8-mediated autoimmune diseases.
Results
Late recruitment of naı ¨ve CD8 cells during acute LCMV
infection results in reduced expansion and contraction
but increased memory conversion in the spleen
Introduction of small numbers of TCR-Tg, LCMV-specific
CD8 cells accurately reproduces the natural anti-LCMV response
without profoundly altering viral clearance and T cell expansion
kinetics. In contrast, large number of naı ¨ve antigen-specific T cells
can alter the physiological immune response and clearance of
LCMV and the amount of the endogenous physiological cytokines
and chemokines levels [34,35]. Therefore, in order to better mimic
the natural, acute CD8 anti-LCMV T cell response, we chose to
adoptively transfer only relatively small numbers (2610
3)o f
traceable TCR-Tg LCMV-specific CD8 GFP
+ T cells (GP33–41-
specific –P14) into C57BL/6 LCMV Arm infected mice. To study
how the timing at which a naı ¨ve T-cell enters an antiviral response
affects its proliferation and memory conversion, P14/GFP
+ CD8
T cells were either transferred on day 0 (early) or day 3 (late)
postinfection. We reasoned that cells that were transferred later
post infection would have less opportunity to encounter viral
antigen in vivo, because LCMV antigenic load usually peaks 2–3
days after infection and virus is cleared by day 7 from most organs
it shows tropism [36,37]. To circumvent differences in immune
and viral kinetics between the day 0 and day 3 groups, mice that
received P14/GFP
+ cells on day 0 also received P14/GFP
2 cells
on day 3, while mice that received P14/GFP
+ cells on day 3 had
also received P14/GFP
2 cells on day 0 (Table 1). As shown in
Fig. 1, numbers of GFP
2 GP33–41-specific effector cells on day 8
and day 45 p.i. in both groups were identical and not significantly
different from mice that had received no P14 cells. Thus,
introduction of low numbers of P14 T cells did not significantly
alter the general kinetics of the antiviral immune response and
therefore is a valid approach to differentially track early and late
transferred cells within the GP33–41-specific T cell response against
acute LCMV infection.
C57BL/6 mice were analyzed on days 8, 15 and 45 p.i. for the
presence of GFP
+ cells. The percentage or total numbers of
transferred P14/GFP
+ CD8 T cells in the spleen, blood, and
mesenteric lymph nodes (mLN) for early and late transferred cells
are shown in Fig. 2A–C. As expected, the response kinetics of the
P14 T cells transferred early were similar to the endogenous
antigen-specific populations: defined clonal expansion, contraction
and memory conversion phases were observed. In contrast, P14/
GFP
+ cells transferred 3 days late displayed only a small degree of
proliferation particularly and consistently in the spleen, showing
that T cells that encounter their cognate antigen early during the
immune response make up the majority of the responding
population. The frequency of memory P14/GFP
+ cells within the
CD8 population was identical between early and late transferred
groups in all lymphoid organs analyzed (data not shown). However,
when we determined the fate of the total P14 transferred cells
present at the peak of the response by analyzing the percentage of
cells remaining in the contraction and memory phases (normalized
for D8, fold-change), a much greater output in memory cells in the
late transferred compared to the early transferred cells was seen in
the spleen (Fig. 2D–F). Overall, P14 T cells introduced early during
the initial phase of the antiviral immune response exhibited much
greater expansion and contraction rates compared to late ones in
thespleen.Ontheotherhand,cellsexposedtoreduced viralantigen
in vivo (late), do not expand to the same extent, yet convert to
memory T cells with greater efficiency.
The majority of late transferred CD8 T cells present at the
peak of the anti-LCMV response convert to memory
displaying a CM phenotype
It is evident from the results discussed above that the majority of
naı ¨ve T cells recruited late during the immune response displayed
a higher degree of memory conversion in the spleen. Our results
Table 1. Late and early transferred group of P14 LCMV-
specific naı ¨ve CD8 T cells.
Group D=0 cells transferred D=3 cells transferred
Early 2610‘3 P14/GFP
+ 2610‘3 P14/GFP
2
Late 2610‘3 P14/GFP
2 2610‘3 P14/GFP
+
doi:10.1371/journal.pone.0014502.t001
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response can become memory cells at higher efficiency than naı ¨ve
CD8 cells that join the antiviral immune response early and
expand maximally. Next, we wanted to investigate whether the
relative contribution to the CM or EM CD8 T cell pool differs
between the early and late transferred cells. In order to compare
memory subset development between the early and late trans-
ferred cells, additional characterization based on CD44 and
CD62L expression was done. We chose CD62L since it is a key
marker that distinguishes EM from CM memory T cell subsets
along with the expression of CD44. Of note, all P14 cells
transferred late or early displayed CD44 upregulation at the peak
of the response in the spleen (data not shown). Later on, at the
contraction phase, more than 70% of the cells displayed an EM
phenotype CD44
hiCD62L
lo in both groups (Fig. 3A–B). Interest-
ingly though, while in the early transferred group almost one third
of the cells displayed CM phenotype at the memory phase, a much
greater proportion of cells (.70%) in the late transferred group
displayed CM features (Fig. 3D–E). These phenotypic character-
istics were somewhat different in the mLN and blood, since in both
early and late transferred cells, preferential high levels of both
CD44 and CD62L expression were seen at the contraction and
memory phase, indicating that these cells fall within the CM
population (data not shown).
In addition, in order to differentiate between the functional
capacities of CM and EM cells, IL-2 production from the
CD8
+GFP
+ population was measured 45 days after infection,
following ex-vivo stimulation with the class I, P14-specific peptide
GP33–41 (Fig. 3C&F). Indeed, IL-2 production was greatly
enhanced in terms of total number by late transferred cells,
consistent with their predominant CM phenotype. This preferen-
tial IL-2 production together with re-expression of CD62L by the
late transferred group suggests that the strength of antigen
stimulation received during the priming phase of the response
was reduced compared to the early transferred cells [20,21]. In
addition, memory cells generated from these late transferred CD8
T cells adopt homing properties, characteristic of the CM subset.
Early and late transferred CD8 cells display similar
functional characteristics at the effector and memory
phases
As effector T cells differentiate into memory cells, they acquire a
CM or EM phenotype and retain the potential to rapidly produce
IFNc and TNF when exposed to antigen. We compared the ability
of P14 early and late transferred cells to secrete cytokines in
response to antigen during the primary antiviral effector and
memory phase. As shown in Fig. 4, intracellular cytokine staining
after gating on P14/GFP
+ cells following stimulation with the class
I-restricted epitope GP33–41 showed no difference in IFNc and
TNF production at the peak of the response day 8 p.i. (D8)
between early and late transferred groups. Similar analysis
conducted at the memory stage day 45 p.i. (D45), in which early
transferred cells displayed a predominantly EM phenotype while
late transferred cells had become CM in the spleen, showed that
both groups exhibited similar cytokine production characteristics
indicative of functional memory. In conclusion, although cells
engaged late in the immune response are exposed to less
inflammatory signals and antigen and therefore proliferate and
contract less, they acquire normal CM characteristics and are fully
able to produce antiviral effector cytokines.
Late transferred cells display a memory precursor
phenotype at the peak of the response
Recently it has been suggested that memory cell precursors can
already be identified at the peak of the response by high levels of
Figure 1. No significant effect in the endogenous GP33–41 LCMV-specific response after the transfer of 2610
3 P14 CD8 T cells.
Spleens from mice receiving P14GFP
+ on day 0 or 3 after infection were collected and analyzed by pentamer staining on day 8 and day 45 after
infection (A). The total number of antigen-specific cells per spleen was calculated by multiplying the percent of GFP
2CD8/GP33 pentamer double
positive cells by the total number of cells isolated from the spleen of each mouse. A representative dot plot of percentage of GP33 specific CD8 T cells
on day 8 and day 45 is shown in (B). Representative data are from one of two experiments. Differences are not statistically significant.
doi:10.1371/journal.pone.0014502.g001
CD8 Memory in Low Viral Load
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Since we observed that the majority of naı ¨ve P14 cells that enter
the immune response at a later time point remain as memory, we
performed a phenotypic analysis in order to examine whether the
late transferred cells display a memory precursor phenotype early,
by the eighth day after infection with LCMV. To this end, naı ¨ve
P14/GFP
+ cells from late and early transferred groups were
analyzed by flow cytometry for the expression levels of CD127 and
KLRG1. Interestingly, the majority of P14 transferred cells had
downregulated the expression levels of CD127 (Fig. 5), which was
even more pronounced in the early transferred group. Important-
ly, comparison of KLRG1 levels detected within the P14/GFP
+
cells at the peak of the response (Fig. 5A) between early and late
transferred cells showed a strong correlation of greater memory
formation in the later group with the lower expression of KLRG1
levels in these samples (Fig. 5B–C). Based on the recent
classification for memory precursor effector cells (MPECs), the
IL-7Ra
hi/KLRG1
lo cell frequency was much greater in the late
(13.8%) than early (2.8%) transferred P14/GFP
+ cells at the peak
of the anti-LCMV response (Fig. 5B). Collectively, these data
indicate that naı ¨ve CD8 T cells recruited later in the antiviral
immune response largely convert into memory and their fate is
determined as early as the initial stages of their activation.
Duration of antigen exposure is the decisive factor for
memory T cell fate
Our results prompted us to investigate the signals that are
necessary to enhance memory conversion of the late transferred
cells. Initially we hypothesized that their greater memory
conversion was either due to differences in i) antigen load (less
Figure 2. Late recruited naı ¨ve CD8 cells convert at a higher efficiency to memory cells in the spleen. Spleen, blood and mesenteric
lymph node (mLN) cells from mice receiving P14/GFP
+ early (day 0) or late (day 3) post infection (and GFP
2 cells on days 3 and 0, respectively) were
analyzed on days 8, 15 and 45 p.i. with flow cytometry. The total CD8
+GFP
+ number or the GFP
+ percentage gated on CD8 T cells is depicted for each
tissue (A–C). The CD8
+GFP
+ percentage for the spleen and mLN was multiplied with its respective total lymphocyte number. The fold-change from
day 8 in the total GFP
+ is shown in (D–E). The fold-change was calculated as follows: the ratio of the measured CD8
+GFP
+ percentage or the total
number on day 8, minus day 15 or day 45, divided by the value on day 8, times 100. (i.e. CD8
+GFP
+ % for day 8=1 and day 15=0.5, while day 45=0.2,
fold-change on day 15=[(120.5)/1]x100=50% and on day 45=[(120.2)/1]x100=20%). The total GFP
+ in CD8 T cells output on day 15 and day 45
from day 8’s input is represented (F). *, p,0.05, **, p,0.005, ***, p,0.001, NS, not statistically significant. Similar data were obtained from at least five
independent experiments with three to four mice per group.
doi:10.1371/journal.pone.0014502.g002
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activation status of the APCs or iii) due to greater IL-7Ra levels
expressed by P14 cells entering the response at a later stage. In
order to identify parameters other than viral antigenic load that
differ and could affect memory conversion of antiviral CD8 T
cells, mice that had received naı ¨ve P14/GFP
+ cells late were
treated the day after the cell transfer with polyI:C (100 mg/mouse),
CpG (200 mg/mouse) or recombinant IFNc (50 ng/mouse). As
shown in Fig. S1, treatment with any of these three regiments did
not alter memory conversion. In parallel to these experiments, we
were able to recapitulate the enhanced memory conversion of P14
early transferred naı ¨ve CD8 T cells after recombinant IL-7
treatment as previously described (30) (data not shown).
In order to address in more detail whether cumulative antigen
exposure over time was the decisive factor for T cell fate
determination, we took advantage of an additional approach.
P14/GFP
+ cells were transferred to LCMV infected recipients
early, which were previously and continuously treated with
ribavirin (Rebetol) orally on a daily basis. Ribavirin is a nucleoside
analog that is an effective antiviral treatment against arenaviruses
[38]. Each recipient mouse received 8 mg ribavirin for 10
consecutive days, starting seven days prior to LCMV infection
and continuing until three days after infection. As shown in Fig. 6A,
ribavirin treatment reduced the LCMV copies in the kidney
significantly three days but not six days after infection. The
reduction in virus levels caused the endogenous GFP
2/GP33-
pentamer
+ and transferred GFP
+/P14 cells to drop at the peak of
the response (Fig. 6B and data not shown). However, and in
agreement with our late versus early transfer approach, memory
development was favored (Fig. 6B–D). Although in this scenario
the contraction phase was not diminished compared to late
transfer experiments, cells contributed again more effectively to
the ensuing memory pool. Importantly, at the memory phase, P14
early transferred cells in the group of mice treated with ribavirin,
there was an increased proportion of CD62L
hi CM cells (Fig. 6E).
Altogether, our results suggest that by reducing the antigen load
alone, we do not compromise memory T cell development but
rather promote differentiation of the CM subset.
Figure 3. Late transferred CD8 T cells display a gradual shift from a CD62L
lo (EM) phenotype to a CD62L
hi (CM) phenotype. C57BL/6
mice infected with LCMV received purified CD8 T cells isolated from naı ¨ve P14/GFP
+ mice on day 0 and day 3. On days 15 and 45, GFP
+CD8 T cells
from the spleen, blood and mLN were examined for the expression of CD44 and CD62L. The percent expression of CD44
hi and CD62L
lo on CD8
+GFP
+
gated cells is shown in (A) and in (D) for day 15 and 45 respectively. The percentage of CD44
hi/CD62L
hi expression gated on CD8
+GFP
+ is depicted in
(B) and (E) for day 15 and 45 respectively. The percentage and total number of CD8
+GFP
+ cells producing IL-2 on day 45 are displayed accordingly in
(C) and (F). *, p,0.05, **, p,0.005, NS, not statistically significant. Similar data were obtained from at least two independent experiments.
doi:10.1371/journal.pone.0014502.g003
CD8 Memory in Low Viral Load
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In this study we demonstrated that LCMV-specific naı ¨ve CD8
T cells that experience reduced cumulative antigen exposure
during the anti-LCMV response convert more efficiently into
memory CD8 T cells. The majority of cells activated late exhibit
an activated phenotype with CD44 upregulation and CD62L
downregulation at the acute and contraction phases indicative of
previous antigen encounter (data not shown and Fig. 3A–B).
However, cells exposed to low levels of antigen become imprinted
with a distinct long-term differentiation program: such cells do not
expand and consequently do not contract to the same extent, while
they primarily survive as CM cells (Fig. 7). Most CD8 T cells
recruited at a later stage downregulate IL-7Ra levels, while
maintaining low levels of KLRG1 expression at the peak of the
response (Fig. 5). Given their high conversion rate into memory,
perhaps a significant proportion of KLRG1
lo/IL-7Ra
lo cells
should be considered as memory precursor cells, which contradicts
the current classification of MPECs as IL-7Ra
hi cells. In earlier
studies, constitutive IL-7Ra expression had a minimal effect on the
formation and function of effector and memory CD8 cells,
suggesting that IL-7Ra levels do not identify memory CD8 T cell
precursors (31). KLRG1
lo cells though, irrespective their IL-7Ra
levels, seem to give rise to IL-7Ra
hi long-lived memory cells (33).
Taken together, KLRG1 and to a lesser extent IL-7Ra levels seem
to best define memory precursor frequency as early as at the peak
of the response.
Since naı ¨ve cells entering the immune response at a later time
point express higher CD127 levels, we investigated whether
blocking IL-7Ra during the contraction phase would affect the
outcome of memory T cell development. However, we did not
observe consistent effects after CD127 blockade on memory CD8
conversion (data not shown). Together, our results suggest that
anti-CD127 treatment at the contraction phase does not have a
clear impact on naı ¨ve CD8 T cell memory formation, similar to
what was previously described [12].
Exogenous treatment with inflammatory stimuli could not
reverse preferential memory conversion of the late recruited cells,
suggesting that the antigenic load is likely the main factor that
contributes to memory formation, possibly determined by the
number of T cell to APC contacts. Cells that encounter more
antigen or more recently infected APCs receive stronger antigenic
stimulation and co-stimulation, proliferate more vigorously and
therefore experience greater activation-induced cell death or
become imprinted as senescent effectors or SLECs, thus making
conversion to memory less likely. In agreement, treatment with
ribavirin prior to early P14/GFP
+ cell transfer, while reducing the
viral load and the expansion of cells at the peak of the response,
had a positive impact on memory formation. Overall, our results
support the decreasing-potential model (6), which proposes that
one of the main factors controlling memory output of a given
population recruited in the immune response is the duration of
antigen exposure during priming. CD8 T cells recruited later in
the response, despite receiving a weak stimulation, become
imprinted with a memory differentiation program, perhaps
because the received signal is not adequate enough to trigger the
death pathway. In addition, full differentiation into effector cells is
not prerequisite for memory conversion [39]. In agreement with
our findings, during persistent viral infection, prolonged and
strong antigenic encounter decreases the contribution to the
memory pool by constantly eliminating effector T cells and
MPECs [4,40].
Recent reports have also examined the effect of timing and
antigen load on T cell priming and memory development
[21,34,35]. In one study using a vaccinia viral infection model,
the initial burst size of hemagglutinin (HA)-specific CD8 effector T
cells in response to recombinant vaccinia virus encoding HA (rVV-
HA) correlated with the magnitude of the long-term memory pool
size (37). The major caveat of this study was that rather large
numbers of cells were transferred (1610‘5) without the inclusion of
control co-transfers, which may have masked the endogenous
physiological response. Another study, using a recombinant
vesicular stomatitis virus (VSV) -expressing OVA (VSV-OVA)
infection model, found that ‘‘latecomer’’ OT-I cells were not
preferentially recruited to the surviving memory pool (21),
contrasting our results where naı ¨ve CD8 T cells activated later
Figure 4. Early and late recruited CD8 cells display similar
functional characteristics during the antiviral effector and
memory phases. Spleens were collected and analyzed 8 and 45 days
after infection. Splenocytes were cultured with the LCMV MHC-I peptide
GP33 before staining for intracellular IFNc and TNF. The percentage (A)
and total number (B) of TNF/IFNc double positive cells after gating on
the CD8
+GFP
+ population are shown. The total number of antigen-
specific cells per spleen was calculated by multiplying the percent of
TNF/IFNc double positive cells by the total number of cells isolated
from the spleen of each mouse. A representative dot plot of TNF and
IFNc expression by GFP
+CD8 gated cells is shown in (C). Representative
data are from one of two experiments. Differences are not statistically
significant.
doi:10.1371/journal.pone.0014502.g004
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the VSV study, engrafted OT-I cells exceeded the natural OVA-
specific precursor frequency, with potential effects on the
physiological response and memory formation. Here, we have
recapitulated the endogenous physiological anti-LCMV response
by transfer of low numbers of virus-specific CD8 T cells with
minimal impact on the endogenous anti-viral CD8 T cell response.
With this system, we found that specific low frequency naı ¨ve CD8
T cells acquire distinct differentiation fates depending on the
antigen dose and to a lesser extent the inflammatory response.
There have been recent examples of residual antigen persisting
long after infection in mouse virus infection models [40,41]. Our
results indicate that memory formation may continue to occur in
conditions of low antigen load even after virus is effectively
cleared.
Studies using a novel barcode technology to mark individual T
cells showed that single naı ¨ve CD8 T cells could yield
heterogeneous populations of effector and memory CD8 T cells
(38). These results suggest that effector and memory fates are not
imprinted by distinct APC or antigen/timing signals delivered
during initial priming. We also found that naı ¨ve CD8 T cells can
adopt multiple fates under a variety of conditions and that the
timing of activation during infection is an important factor. In
summary, our results support that sufficient and effective memory
Figure 5. Majority of late transferred cells display a memory precursor phenotype at the peak of the anti-LCMV response. Naı ¨ve P14
GFP
+ cells from the late and early transferred groups were analyzed by flow cytometry for the expression levels of CD127 and KLRG1. The GFP
+ cell
percentage within the total CD8 population is depicted in the first 3 horizontal graphs for the early and late transferred cells and the naı ¨ve control (A).
A representative dot plot of CD127 and KLRG1 expression is shown for all three groups (B). Histogram overlay for the expression of KLRG1 and CD127
in P14/GFP
+CD8
+ early versus late transferred cells and naı ¨ve controls at the peak of the response (C).
doi:10.1371/journal.pone.0014502.g005
CD8 Memory in Low Viral Load
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dose, providing important implications for vaccine design.
Materials and Methods
Mice
Eight- to 10-wk-old male C57BL/6 mice were purchased from
Jackson laboratories. Naı ¨ve TCR Tg P14 mice were bred to GFP
+
(both on the C57BL/6 background) to obtain GP33-specific,
GFP
+ double Tg mice (P14/GFP
+). Expression of both transgenes
was confirmed by flow cytometry after testing for GFP, Va2, and
Vb8.1/8.2 expression. All mice were maintained under specific-
pathogen-free conditions at the La Jolla Institute for Allergy and
Immunology (LIAI) and handled in accordance with the LIAI
Animal Care and Use Committee approved protocols. The
experiments for this study were conducted according the approved
mouse protocol: #AP117-MvH2-0510 [600] (approved 05/25/
10) ‘‘Viruses and autoimmunity’’.
CD8 T cell negative selection and adoptive transfer
Naı ¨ve CD8 T cells were purified from splenocytes of P14/GFP
+
or P14/GFP
2 mice by negative selection using the following
purified monoclonal antibodies: anti-B220, anti-CD4, anti-
CD11c, anti-FccRII (clone 2.4G2), anti-mouse MHC Class II I-
A/I-E and anti-CD11b. All antibodies were from BioLegend (San
Diego, CA, USA). CD8 T cells were then purified by magnetic
separation using the Sheep anti-Rat IgG coated Dynabeads
(Invitrogen, San Diego, CA, USA). Before transfer, cells were
Figure 6. Ribavirin treatment reduces LCMV antigenic load impacting memory CD8
+ T cell development. Mice were treated with
ribavirin (Rebetol) orally on a daily basis. Each mouse received 8 mg ribavirin for 10 consecutive days, starting seven days prior to LCMV Arm infection
and continuing until three days after infection. Mice received P14/GFP
+ CD8 T cells the same day of infection. Viral load was quantified with qPCR in
the kidneys of the infected mice 3 and 6 (A) days after infection. Significant decrease in viral load was detected only on day 3, *, p,0.05, NS, not
statistically significant. The total CD8
+GFP
+ number (B) and Fold-change (C) was calculated as in Fig. 2 for the spleen for days 8, 15 and 45 after
infection. The percentage of total CD8
+GFP
+ cells remaining on days 15 and 45 from day’s 8 input is represented graphically in (D). Representative
flow cytometry plots showing the CD44/CD62L profile of the cells on day 45 after infection gated on CD8
+/GFP
+ is shown in (E). Almost double CM
(CD44
hi/CD62L
hi) cell frequency can be detected in the group of mice treated with ribavirin.
doi:10.1371/journal.pone.0014502.g006
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3 of naı ¨ve
P14/GFP
+ or P14/GFP
2 CD8 T cells were adoptively transferred
into the tail vein (intravenously, i.v.) on days 0 and 3 post infection
(p.i.). Mice that received P14/GFP
+ cells early, received P14/
GFP
2 late, whereas the ones that received P14/GFP
+ cells late,
received P14/GFP
2 early.
Virus
Mice were infected with 10
4 PFU of LCMV strain Armstrong
(53b) by intraperitoneal (i.p.) injection.
Treatments
Mice were treated once on day 4 after infection with LCMV
with 100 mg/mouse polyI:C (Amersham Pharmacia) i.p. or 50 ng/
mouse recombinant mouse IFNc (BD Pharmingen, San Diego,
CA, USA) i.p. or with 200 mg/mouse CpG i.v. Anti-CD127
(125 mg/mouse) treatments (clone SB/14 BD Pharmingen or
clone A7R34 Biolegend) were conducted i.p. in the contraction
phase on days 8-10-12-14 after LCMV infection. Mice were
treated with ribavirin (Rebetol, USP- NDC 0085-1318-01) orally
on a daily basis. Each mouse received 8 mg ribavirin for 10
consecutive days, starting seven days prior to LCMV infection and
continuing until three days after infection.
Flow cytometry
Single cell suspensions were prepared from spleen, peripheral
blood and mesenteric lymph nodes (MLN) from all groups. After a
2.4G2 block step, cells were stained with the conjugated antibodies
for cell surface markers. PE-conjugated H2-D
b/GP33 pentamers
were purchased from ProImmune and stained as previously
described [42]. Directly conjugated antibodies, CD8-PerCP,
CD62L-APC, CD127-PE or PeCy7 (BD Pharmingen), CD44-
APCCy7, CCR7-PeCy7, KLRG1-PE (e-Bioscience, San Diego,
CA, USA) and CD25-PB (Biolegend) were used. For surface
staining, cell suspensions were incubated at 4uC for 30 min. After
surface staining, cells were fixed in 4% paraformaldehyde (Sigma-
Aldrich). D
bGP33 and class I pentamers were obtained as PE
conjugates from Proimmune and used as described previously. For
intracellular cytokine analysis, single cell suspensions were
stimulated in vitro for 3 hours with 1 mg/ml MHC class I-
restricted viral peptides GP33–41 (GP33) (Abgent, San Diego, CA,
USA). Cells were stained for surface expression of CD4 and CD8,
fixed, permeabilized, and stained for intracellular IL-2, IFNc and
TNF. After staining, cells were processed on LSRII (BD
Biosciences) and results were analyzed using FlowJo (Tree Star).
Quantitative PCR
Kidney samples were surgically removed and frozen at 280uC,
then weighed and homogenized. RNA was isolated using the
RNAqueous mini spin column based system (Ambion). RNA was
eluted from RNAaqueous spin columns in a volume of 20 ml. 8.5 ul
of RNA was used in a 10 ml cDNA reaction with SuperScript III
Reverse Transcriptase (SSIII) (Invitrogen, Carlsbad, CA) and a GP-
R primer (S pos. 970–991), GCAACTGCTGTGTTCCCGAAAC
GP-R at 55uC for 1 hr in a programmed PCR thermocycler. 10 ml
of cDNA was used as template for a 25 ml qPCR reaction using
SYBR Green kit (Roche), plated in 96 well plate format and run on
a LightCycler 480 (Roche). Amplification was done for 40 cycles,
with each cycle consisting of two steps: 95uC, 15 sec; 60uC, 30 sec.
All qPCR samples ran in triplicate, with water as a negative control
and LCMV as a positive control. Standard curves were generated
using linearized pSG5-GP plasmid.
Statistical analysis
Data are expressed as a mean 6 SD. The statistical significance
of the difference between means was determined using the two-
tailed Student’s t-test. *, p,0.05, **, p,0.005, ***, p,0.001.
Supporting Information
Figure S1 Recruitment of late transferred cells into the memory
T cell pool is not influenced by inflammatory agents. Mice were
infected with acute LCMV and received P14/GFP
+ CD8 T cells
the same day or 3 days after infection. Groups of mice were
treated 1 day after cell transfer with recombinant mouse IFNc,
polyI:C, CpG, or no treatment, as described in the Materials and
Methods section. The percentage of GFP
+ cells remaining on day
28 from day 8’s input is represented graphically.
Found at: doi:10.1371/journal.pone.0014502.s001 (1.01 MB TIF)
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Figure 7. Antigenic load affects the expansion and contraction phase of an anti-LCMV response positively whereas it is inversely
related to memory conversion. This schematic represents that when P14/GFP
+ T cells were introduced at a later time point of acute LCMV
response a much less expansion followed by almost no contraction was observed. Nevertheless, a much larger proportion of those cells found on D8
converted and contributed to the memory cell pool.
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